TURPENTINE OINTMENT

Ukraine

The drug is used to relieve pain in neuralgia, myositis, and arthritis. It has a distracting, analgesic, mild anti-inflammatory, and antiseptic effect.

Brand name TURPENTINE OINTMENT
Dosage form ointment
Active substance / Dosage
Prescription type over-the-counter (OTC)
ATC code
Registration number UA/8606/01/01
Manufacturer Ternofarm LLC
TURPENTINE OINTMENT ointment

Frequently asked questions

How should Turpentine ointment be used correctly?

Adults should rub the ointment into the painful areas of the skin 2–3 times a day. The duration of treatment depends on how quickly the symptoms of the disease subside.

What are the possible side effects of Turpentine ointment?

Local allergic reactions are possible: itching, swelling, redness, burning, or rash. In rare cases, more serious reactions may occur: rapid heartbeat, dizziness, low blood pressure, convulsions, or loss of consciousness.

Who should not use this drug?

Use is contraindicated in cases of severe kidney and liver disease, skin diseases, as well as hypersensitivity to the ingredients. The ointment is not recommended for children, pregnant women, or breastfeeding women.

Can the ointment be mixed with other agents?

The ointment is chemically incompatible with iodine solution.

What should be done if the ointment gets into the eyes or onto damaged skin?

The ointment must not be applied to damaged areas of the skin or to mucous membranes. If the ointment accidentally gets into the eyes, they should be thoroughly rinsed with plenty of running water.

Instructions for use

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT SKYPIDARNAYA OINTMENT

Composition:

Active substance: purified turpentine oil;

1 g of ointment contains 0.2 g of purified turpentine oil;

Excipients: white soft paraffin, purified water, emulsifier T-2.

Pharmaceutical form. Ointment.

Main physicochemical properties: ointment of white color with a yellowish tint and the smell of turpentine. The ointment should be homogeneous in appearance.

Pharmacotherapeutic group.

Agents applied locally for joint and muscle pain.

ATC code M02AX10.

Pharmacological properties.

Pharmacodynamics. "Turpentine ointment" has a counterirritant, mild anti-inflammatory, antiseptic, and analgesic effect. The counterirritant effect is associated with its ability to penetrate through the epidermis and cause reflex changes due to stimulation of skin receptors. A certain role is also played by the release of biologically active substances from the skin, in particular histamine.

Pharmacokinetics. Not studied.

Clinical characteristics.

Indications.

Neuralgias, myositis, arthritis.

Contraindications.

Severe kidney and liver diseases, skin diseases of various etiologies, hypersensitivity to the drug.

Interaction with other medicinal products and other forms of interaction.

"Turpentine ointment" is chemically incompatible with iodine solution.

Special precautions for use.

Avoid contact of the ointment with mucous membranes and eyes! If accidental contact with eyes occurs, rinse them thoroughly with plenty of running water.

Do not apply to damaged areas of the skin.

Use during pregnancy or breastfeeding.

The use of the medicinal product is contraindicated during pregnancy or breastfeeding.

Ability to influence reaction rate when driving or operating machinery.

Caution should be exercised when driving or operating machinery due to the possibility of generalized adverse reactions occurring (see section "Adverse reactions").

Method of Administration and Dosage.

Apply "Turpentine Ointment" externally to adults by rubbing it into painful areas 2–3 times daily.

The duration of use should be determined based on the course of the disease.

Consult a physician if symptoms do not improve during treatment with the medicinal product or if any adverse reactions occur.

Children.

There is no experience with the use of this medicinal product in children; therefore, the ointment is not recommended for use in this patient group.

Overdose.

An increased sensitivity to the drug and intensification of adverse effects may occur.

Adverse reactions.

In case of hypersensitivity to the drug, local allergic reactions may occur (including itching, swelling, skin redness, burning sensation, rash). In individual cases, generalized allergic reactions may occur (urticaria, rapid heartbeat, decreased blood pressure, dizziness, seizures, loss of consciousness).

Shelf life. 2 years.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging.

25 g in tubes, in cardboard boxes or without a box.

Availability. Over-the-counter (without prescription).

Manufacturer/Applicant.

LLC "Ternopharm".

Manufacturer's address and location of its business activities / Applicant's address.

4 Fabrychna Street, Ternopil, 46010, Ukraine.

Similar drugs

Brand name Dosage form Active substance / Dosage Manufacturer
APIZATRON ointment Lichtenheldt GmbH Pharmaceutical Factory (manufacturing in bulk, primary packaging, secondary packaging, quality control)
BAINVAIL OINTMENT INTENSIV ointment Dr. Theiss Naturwaren GmbH (quality control and batch release; manufacturing of unpackaged products, primary and secondary packaging)
CAPSIKAM ointment JSC Tallinn Pharmaceutical Plant
DR. THEISS'S OINTMENT WITH COMFREY ointment
comfrey tincture · 10 g/100 g
Dr. Theiss Naturwaren GmbH (batch release authorization; manufacturing of unpackaged products, primary and secondary packaging)
FLAMIDEZ PHYTPLUS ointment Encube Ethicals Private Limited
GEVKAMEN ointment
levomenthol · 180 mg
camphor · 100 mg
clove oil · 10 mg
PJSC "Fitofarm"
HEVACAMEN ointment Ternofarm LLC
HEVACAMEN ointment DKP "Pharmaceutical Factory" LLC
HEVACAMEN ointment
menthol · 0.18 g
camphor · 0.10 g
clove oil · 0.01 g
PJSC Pharmaceutical Factory "Viola"
TURPENTINE OINTMENT ointment PJSC "Fitofarm"
VIPROSAL V® ointment JSC Tallinn Pharmaceutical Plant
ZHIVOKOST ointment PJSC Pharmaceutical Factory "Viola"

The original data is available in the language of the country of manufacture.

Data source: State Register of Medicinal Products of Ukraine

Data last verified: August 13, 2026